High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids. 1990

M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
Pediatric Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

A paired-ion high-performance liquid chromatographic method was developed to measure concentrations of 2',3'-dideoxyinosine (ddI) in human plasma, urine and cerebrospinal fluid. Samples were prepared using a solid-phase extraction technique which allows for a five-fold concentration of the drug. 2'-Deoxyguanosine was added as an internal standard prior to the extraction. Recoveries for 2'-deoxyguanosine and ddI were 80 +/- 15 and 85 +/- 10%, respectively. Extracted samples were then injected onto a C18 column and eluted isocratically with a mobile phase containing 0.1% of the ion-pairing reagent, heptafluorobutyric acid, and 5% acetonitrile. The retention time was 7.4 min for 2'-deoxyguanosine and 8.4 min for ddI. The lower limit of detection for ddI is 0.1 microM. Using this technique the acid lability of ddI was demonstrated and the plasma concentration versus time profile from a patient receiving the drug was examined.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D001826 Body Fluids Liquid components of living organisms. Body Fluid,Fluid, Body,Fluids, Body
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D016049 Didanosine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. 2',3'-Dideoxyinosine,Dideoxyinosine,ddI (Antiviral),NSC-612049,Videx,2',3' Dideoxyinosine,NSC 612049,NSC612049

Related Publications

M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
February 1991, Journal of chromatography,
M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
February 1990, Journal of chromatography,
M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
November 1990, Journal of chromatography,
M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
August 1996, Journal of pharmaceutical sciences,
M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
January 1989, Therapeutic drug monitoring,
M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
June 1988, Journal of chromatography,
M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
May 1991, Journal of chromatography,
M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
April 1986, Journal of chromatography,
M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
September 1983, Journal of chromatography,
M E Carpen, and D G Poplack, and P A Pizzo, and F M Balis
May 1985, Journal of chromatography,
Copied contents to your clipboard!